3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
7
Phase 1
5
Phase 3
4
Phase 2
3
Phase 4
2
Phase 1/2
1
Status
Unknown
2
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
265
Carcinoma, Non-Small-Cell Lung
219
Neoplasms
218
Leukemia, Myeloid, Acute
193
Multiple Myeloma
178
Colorectal Neoplasms
174
Melanoma
165
Prostatic Neoplasms
163
Lymphoma
145
Leukemia
142
Lymphoma, Non-Hodgkin
133
Glioblastoma
130
Pancreatic Neoplasms
127
Neoplasm Metastasis
118
Lung Neoplasms
118
Leukemia, Lymphocytic, Chronic, B-Cell
118
Ovarian Neoplasms
112
Precursor Cell Lymphoblastic Leukemia-Lymphoma
106
Recurrence
97
Myelodysplastic Syndromes
93
Hodgkin Disease
92
Lymphoma, Large B-Cell, Diffuse
89
Lymphoma, Follicular
89
Lymphoma, Mantle-Cell
83
Head and Neck Neoplasms
79
Carcinoma, Renal Cell
79
Brain Neoplasms
77
Sarcoma
73
Carcinoma, Hepatocellular
73
Squamous Cell Carcinoma of Head and Neck
71
Interventions
tislelizumab
1
spartalizumab
1
Immune Checkpoint Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Completed
×
Hyperthermia
×
Clear all
NCT06022692
2023-09-05
HEAIS001
Zhejiang Hospital
Phase 1/2
Completed
18 enrolled